These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24009625)

  • 21. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
    Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
    Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.
    Fine SW; Al-Ahmadie HA; Chen YB; Gopalan A; Tickoo SK; Reuter VE
    Am J Surg Pathol; 2018 Aug; 42(8):1036-1041. PubMed ID: 29878934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
    Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
    Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal Carcinoma.
    Zhou M; Magi-Galluzzi C
    Surg Pathol Clin; 2008 Dec; 1(1):43-75. PubMed ID: 26837902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
    Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
    Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable.
    Wang Y; Teramoto Y; Miyamoto H
    Hum Pathol; 2023 Aug; 138():112-120. PubMed ID: 37364826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
    Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
    Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraductal carcinoma of the prostate: What we know and what we do not know.
    Chen X; Ding B; Zhang P; Geng S; Xu J; Han B
    Pathol Res Pract; 2018 May; 214(5):612-618. PubMed ID: 29628124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.
    Grosset AA; Dallaire F; Nguyen T; Birlea M; Wong J; Daoust F; Roy N; Kougioumoutzakis A; Azzi F; Aubertin K; Kadoury S; Latour M; Albadine R; Prendeville S; Boutros P; Fraser M; Bristow RG; van der Kwast T; Orain M; Brisson H; Benzerdjeb N; Hovington H; Bergeron A; Fradet Y; Têtu B; Saad F; Leblond F; Trudel D
    PLoS Med; 2020 Aug; 17(8):e1003281. PubMed ID: 32797086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives.
    Voulgari O; Goutas D; Pergaris A; Belogiannis K; Thymara E; Kavantzas N; Lazaris AC
    Curr Issues Mol Biol; 2023 Mar; 45(4):2767-2780. PubMed ID: 37185705
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.
    Shah RB; Nguyen JK; Przybycin CG; Reynolds JP; Cox R; Myles J; Klein E; McKenney JK
    Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Diagnosis of Intraductal Lesions of the Prostate.
    Wobker SE; Epstein JI
    Am J Surg Pathol; 2016 Jun; 40(6):e67-82. PubMed ID: 26848801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
    Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB
    Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinical Impact of Comedonecrosis Within Intraductal Carcinoma of the Prostate.
    Wang Y; Teramoto Y; Weisenthal SJ; Goto T; Miyamoto H
    Arch Pathol Lab Med; 2023 Jan; 147(1):94-99. PubMed ID: 35472669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria.
    Madan R; Deebajah M; Alanee S; Gupta NS; Carskadon S; Palanisamy N; Williamson SR
    Histopathology; 2019 Jun; 74(7):1081-1087. PubMed ID: 30720899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
    Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
    Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.